News RSS Bioethics News.

06/02/2016

We’re spending $107 billion on cancer drugs, but is it worth it?

External Link - Source: Washington Post

A flood of innovative cancer treatments helped fuel an 11.5 percent surge in spending on oncology drugs over the past year — to $107 billion globally, according to a new report. But there’s a crucial question the study can’t quite answer: How much are patients benefiting from this expanding arsenal of high-priced drugs?

This entry was posted in Health Care, Pharmaceuticals. Bookmark the permalink.